DaVita Inc. (DVA)
NYSE: DVA · Real-Time Price · USD
151.85
+4.31 (2.92%)
Dec 20, 2024, 4:00 PM EST - Market closed
DaVita Employees
DaVita had 70,000 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
70,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$180,952
Profits / Employee
$11,824
Market Cap
12.45B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 70,000 | 0 | - |
Dec 31, 2022 | 70,000 | 1,000 | 1.45% |
Dec 31, 2021 | 69,000 | 2,000 | 2.99% |
Dec 31, 2020 | 67,000 | 2,000 | 3.08% |
Dec 31, 2019 | 65,000 | -12,700 | -16.34% |
Dec 31, 2018 | 77,700 | 3,200 | 4.30% |
Dec 31, 2017 | 74,500 | 4,200 | 5.97% |
Dec 31, 2016 | 70,300 | 9,900 | 16.39% |
Dec 31, 2015 | 60,400 | 2,500 | 4.32% |
Dec 31, 2014 | 57,900 | 500 | 0.87% |
Dec 31, 2013 | 57,400 | 4,000 | 7.49% |
Dec 31, 2012 | 53,400 | 12,400 | 30.24% |
Dec 31, 2011 | 41,000 | 4,500 | 12.33% |
Dec 31, 2010 | 36,500 | 2,500 | 7.35% |
Dec 31, 2009 | 34,000 | 1,500 | 4.62% |
Dec 31, 2008 | 32,500 | 1,500 | 4.84% |
Dec 31, 2007 | 31,000 | 2,100 | 7.27% |
Dec 31, 2006 | 28,900 | 900 | 3.21% |
Dec 31, 2005 | 28,000 | 12,700 | 83.01% |
Dec 31, 2004 | 15,300 | 1,500 | 10.87% |
Dec 31, 2003 | 13,800 | 800 | 6.15% |
Dec 31, 2002 | 13,000 | 300 | 2.36% |
Dec 31, 2001 | 12,700 | 500 | 4.10% |
Dec 31, 2000 | 12,200 | -100 | -0.81% |
Dec 31, 1999 | 12,300 | 0 | - |
Dec 31, 1998 | 12,300 | 3,470 | 39.30% |
Dec 31, 1997 | 8,830 | 5,705 | 182.56% |
Dec 31, 1996 | 3,125 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Tenet Healthcare | 106,500 |
Universal Health Services | 96,700 |
Dr. Reddy's Laboratories | 27,048 |
Solventum | 20,098 |
BioMarin Pharmaceutical | 3,401 |
Bio-Techne | 3,050 |
Incyte | 2,524 |
Genmab | 2,204 |
DVA News
- 5 weeks ago - DaVita: Better Results Than Fresenius, But A 'Hold' Due To Valuation - Seeking Alpha
- 5 weeks ago - DaVita's "Move It With Purpose" Sets Record Participation in Support of Global Health - PRNewsWire
- 6 weeks ago - DaVita Inc. to Participate in UBS Global Healthcare Conference 2024 - PRNewsWire
- 7 weeks ago - DaVita Inc. (DVA) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - DaVita misses third-quarter profit estimates on higher costs - Reuters
- 7 weeks ago - DaVita Inc. 3rd Quarter 2024 Results - PRNewsWire
- 7 weeks ago - DaVita Emphasizes Commitment to Whole-Person Care with Investment in National Kidney Foundation PEERS Program - PRNewsWire
- 2 months ago - DaVita Research Centers on Upstream CKD Management; Access & Equity during ASN's Kidney Week 2024 - PRNewsWire